John B. Sanfilippo & Son, Inc.

John B. Sanfilippo & Son missed Q1 2027 expectations, with shares dropping 15% on earnings disappointment and flat industry demand trends. Despite near-term volatility and two consecutive misses, I reaffirm a Buy rating as JBSS trades at a 11-year low P/E of ~10x, with sales and EPS up substantially since then. The high-speed bar production ramp is underway; full optimization and product shipments are expected over the next three quarters, supporting medium-term sales growth.

John B. Sanfilippo & Son, Inc. (JBSS) Q1 2027 Earnings Call Transcript

John B. Sanfilippo & Son NASDAQ: JBSS reported lower first-quarter fiscal 2027 sales and earnings as pricing pressures, a less favorable product mix and higher operating costs weighed on results, while management pointed to stable overall volume trends and growth opportunities in private-label recipe nuts, contract manufacturing and protein-forward bars.

Sanfilippo & Son (JBSS) came out with quarterly earnings of $1.11 per share, missing the Zacks Consensus Estimate of $1.5 per share. This compares to earnings of $1.59 per share a year ago.